- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05761678
Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans) (e-QoL-Trans)
Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort
Transgender people have an identity or an expression gender that differs from the sex assigned to them at the birth. Transgender people and their needs remain misunderstood, and more generally by society. THE transgender populations express poor quality of life compared to the general population. However, very few of studies are interested in these people, in their diversity of paths, trajectories and characteristics of life. More of research is needed to study the quality of life, understand the experiences, in their diversity and in the health, social and life trajectories. Researches must be carried out, in particular on how to interrogate by the seeks out transgender people, in order to prevent stigmatization within population studies.
The main objective of this study is to assess the quality of life of people transgender people during their life trajectory and their transition path, based on validated questionnaires scientifically in French, for major themes of the population concerned (quality of life, social support perceived).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69008
- Recruiting
- Hopital Prive Jean Mermoz
-
Contact:
- Jean-Etienne Terrier, Dr
- Email: docteur.terrier@uroclub.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Transgender people (having a gender identity or expression that differs from the sex assigned to them at birth);
People with any of the following characteristics regarding their trans identity:
- Consultant in one of the transgender reference centers and services for questions/information on the transition;
- Integrated or having completed a course of care with or without gender reassignment surgery;
- Not integrated into a health or care pathway.
- French-speaking people;
- Adults;
- People able to use the tools digital;
- People with Internet or 4G access (total or limited)
Exclusion Criteria:
- People who do not identify as transgender;
- Non-French speaking people;
- Minors
- People who do not know how to handle the tools digital data collection;
- People without Internet access.
- Non-French speaking people, unable to speak understand the research questions
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administrative
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transgender people
Whether they have transitioned or not, with or without reassignment surgery.
|
Quantitative - Validated online self-questionnaires scientifically to assess quality of life and support perceived social. Items created for the study concerning socio-demographic characteristics and satisfaction of health services concerning the accompaniment of the transidentity. Qualitative - Semi-structured interviews based on a guide maintenance. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life estimated with a validated questionnaire administered over the Internet repeatedly every three months.
Time Frame: 3 months
|
Quality of life estimated with a validated questionnaire administered over the Internet repeatedly every three months.
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021-A03156-35
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gender Identity
-
Case Western Reserve UniversityMetroHealth Medical Center; LGBT Community Center of Greater ClevelandUnknown
-
Universitätsklinikum Hamburg-EppendorfUnknownGender Dysphoria | Gender Identity | Transsexualism | Gender Identity DisorderGermany
-
University of Colorado, DenverCompletedGender Dysphoria | Gender Identity | Gender Identity Disorder in Adolescence and AdulthoodUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedGender Dysphoria | Gender Identity | Transsexualism | Gender Identity Disorder | Gender IncongruenceGermany
-
University of Maryland, College ParkEnrolling by invitationGender Identity | Sexual OrientationUnited States
-
Ruhr University of BochumUnknownPropofol | Electroencephalography | Gender IdentityGermany
-
Palo Alto UniversityAmerican Psychological FoundationCompletedKnowledge, Attitudes, Practice | Gender Identity | PrejudiceUnited States
-
Cairo UniversityUnknown
-
Ruhr University of BochumUnknownPropofol Dosage | Electroencephalography | Gender IdentityGermany
-
Karolinska University HospitalNot yet recruitingGender Dysphoria | Gender Identity | Gender Issues
Clinical Trials on Questionnaire quality of life
-
University Hospital, MontpellierPediatric and Congenital Cardiology Department of Necker-enfant malades University...CompletedQuality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years (QoL-CHD-5-7)Congenital Heart DiseaseFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Neuropathy | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingCervical Carcinoma | Endometrial Carcinoma | Vaginal Carcinoma | Malignant Female Reproductive System Neoplasm | Vulvar CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedStage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMalignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCaregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care SettingsMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)TerminatedTongue Cancer | Stage I Squamous Cell Carcinoma of the Oropharynx | Stage II Squamous Cell Carcinoma of the Oropharynx | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage IVA Squamous Cell Carcinoma of the OropharynxUnited States